Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INVIVO BINDING' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 65 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Laruelle, M; Huang, Y
      Vulnerability of Positron Emission Tomography radiotracers to endogenous competition - New insights

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    2. Rice, OV; Gatley, SJ; Shen, J; Huemmer, CL; Rogoz, R; DeJesus, OT; Volkow, ND; Gifford, AN
      Effects of endogenous neurotransmitters on the in vivo binding of dopamineand 5-HT radiotracers in mice

      NEUROPSYCHOPHARMACOLOGY
    3. Duffy, RA; Hunt, MA; Wamsley, JK; McQuade, RD
      In vivo autoradiography of [H-3]SCH 39166 in rat brain: selective displacement by D1/D5 antagonists

      JOURNAL OF CHEMICAL NEUROANATOMY
    4. Moresco, RM; Loc'h, C; Ottaviani, M; Guibert, B; Leviel, V; Maziere, M; Fazio, F; Maziere, B
      Effects of dopamine on the in vivo binding of dopamine D-2 receptor radioligands in rat striatum

      NUCLEAR MEDICINE AND BIOLOGY
    5. Ishiwata, K; Hayakawa, N; Ogi, N; Oda, K; Toyama, H; Endo, K; Tanaka, A; Senda, M
      Comparison of three PET dopamine D-2-like receptor ligands, [C-11]raclopride, [C-11]nemonapride and [C-11]N-methylspiperone, in rats

      ANNALS OF NUCLEAR MEDICINE
    6. Ross, IB; Koyanagi, I; Wallace, MC; Tator, CH
      Autoradiographic [H-3]nimodipine distribution after experimental spinal cord injury in rats

      JOURNAL OF NEUROTRAUMA
    7. Atack, JR; Smith, AJ; Emms, F; McKernan, RM
      Regional differences in the inhibition of mouse in vivo [H-3]Ro 15-1788 binding reflect selectivity for alpha(1) versus alpha(2) and alpha(3) subunit-containing GABA(A) receptors

      NEUROPSYCHOPHARMACOLOGY
    8. Petegnief, V; Saura, J; Dewar, D; Cummins, DJ; Dragunow, M; Mahy, N
      Long-term effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionateand 6-nitro-7-sulphamoylbenzo(f)quinoxalinedione-2,3-dione in the rat basal ganglia: Calcification, changes in glutamate receptors and glial reactions

      NEUROSCIENCE
    9. Ekesbo, A; Torstenson, R; Hartvig, P; Carlsson, A; Sonesson, C; Waters, N; Tedroff, J; Langstrom, B
      Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [C-11]SCH23390 and [C-11]raclopride binding in primate brains

      NEUROPHARMACOLOGY
    10. Lumley, LA; Hull, EM
      Effects of a D-1 antagonist and of sexual experience on copulation-inducedFos-like immunoreactivity in the medial preoptic nucleus

      BRAIN RESEARCH
    11. Zhang, W; Bymaster, FP
      The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D-1, D-2, D-3, 5HT(2A) and muscarinic receptors

      PSYCHOPHARMACOLOGY
    12. HAGBERG G; GEFVERT O; BERGSTROM M; WIESELGREN IM; LINDSTROM L; WIESEL FA; LANGSTROM B
      N-[C-11]METHYLSPIPERONE PET, IN CONTRAST TO [C-11] RACLOPRIDE, FAILS TO DETECT D-2 RECEPTOR OCCUPANCY BY AN ATYPICAL NEUROLEPTIC

      PSYCHIATRY RESEARCH-NEUROIMAGING
    13. NAKANO T; TAKATOKU K; MATOBA Y; IWAMOTO B; NISHIURA M; INOUE O; NISHIMURA T
      ENHANCEMENT OF IN-VIVO BINDING OF [I-123] BETA-CIT BY MK-801 IN RAT-BRAIN

      Synapse
    14. KILBOURN MR; SHERMAN P; ABBOTT LC
      REDUCED MPTP NEUROTOXICITY IN STRIATUM OF THE MUTANT MOUSE TOTTERING

      Synapse
    15. LEVER JR; ILGIN N; MUSACHIO JL; SCHEFFEL U; FINLEY PA; FLESHER JE; NATARAJAN TK; WAGNER HN; FROST JJ
      AUTORADIOGRAPHIC AND SPECT IMAGING OF CEREBRAL OPIOID RECEPTORS WITH AN I-123 LABELED ANALOG OF DIPRENORPHINE

      Synapse
    16. HAZELL AS; HAKIM AM; SENTERMAN MK; HOGAN MJ
      REGIONAL ACTIVATION OF L-TYPE VOLTAGE-SENSITIVE CALCIUM CHANNELS IN EXPERIMENTAL THIAMINE-DEFICIENCY

      Journal of neuroscience research
    17. NAKANO T; SATOH T; MORI K; INOUE O
      IMAGING OF THE SUPER HIGH-AFFINITY BINDING-SITES FOR [H-3]RO15-4513 IN RAT HIPPOCAMPUS - COMPARISON BETWEEN IN-VITRO AND IN-VIVO BINDING

      Neuroscience letters
    18. Murata, T; Matsumura, K; Sihver, S; Onoe, H; Bergstrom, M; Sihver, W; Yonekura, Y; Langstrom, B; Watanabe, Y
      Triazolam-induced modulation of muscarinic acetylcholine receptor in living brain slices as revealed by a new positron-based imaging technique

      JOURNAL OF NEURAL TRANSMISSION
    19. NAKANO T; KOBAYASHI K; HOSOI R; WAKAHARA S; WATANABE Y; NISHIMURA T; INOUE O
      EFFECTS OF THE GABAERGIC SYSTEM ON IN-VIVO BINDING OF [H-3]N-METHYLSPIPERONE

      Neuropharmacology
    20. THORRE K; SARRE S; SMOLDERS I; EBINGER G; MICHOTTE Y
      DOPAMINERGIC REGULATION OF SEROTONIN RELEASE IN THE SUBSTANTIA-NIGRA OF THE FREELY MOVING RAT USING MICRODIALYSIS

      Brain research
    21. BISCHOFF S; GUNST F
      DISTINCT BINDING PATTERNS OF [H-3] RACLOPRIDE AND [H-3] SPIPERONE AT DOPAMINE D-2 RECEPTORS IN-VIVO IN RAT-BRAIN - IMPLICATIONS FOR PET STUDIES

      Journal of receptor and signal transduction research
    22. WANG RF; TAFANI JAM; FRANCES B; BERGON M; COULAIS Y; ZAJAC JM; GUIRAUD R
      EVALUATION OF [I-125] 7-ALPHA-O-IODOALLYL DIPRENOPHINE AS A NEW POTENTIAL SPECT OPIOID RECEPTOR IMAGING AGENT

      Nuclear medicine and biology
    23. OSUGA S; HAKIM AM; OSUGA H; HOGAN MJ
      IN-VIVO UPTAKE OF [H-3] NIMODIPINE INTO BRAIN DURING CORTICAL SPREADING DEPRESSION

      Journal of cerebral blood flow and metabolism
    24. OSUGA S; HOGAN MJ
      IN-VIVO UPTAKE OF [H-3] NIMODIPINE IN FOCAL CEREBRAL-ISCHEMIA - MODULATION BY HYPERGLYCEMIA

      Journal of cerebral blood flow and metabolism
    25. KITTAKA M; GIANNOTTA SL; ZELMAN V; CORREALE JD; DEGIORGIO CM; WEISS MH; ZLOKOVIC BV
      ATTENUATION OF BRAIN INJURY AND REDUCTION OF NEURON-SPECIFIC ENOLASE BY NICARDIPINE IN SYSTEMIC CIRCULATION FOLLOWING FOCAL ISCHEMIA AND REPERFUSION IN A RAT MODEL

      Journal of neurosurgery
    26. KILBOURN M; SHERMAN P
      IN-VIVO BINDING OF (-ALPHA-[H-3]DIHYDROTETRABENAZINE TO THE VESICULARMONOAMINE TRANSPORTER OF RAT-BRAIN - BOLUS VS EQUILIBRIUM STUDIES())

      European journal of pharmacology
    27. LIN CC; KIM HK; PARKER D
      SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF A BENZONAPHTHAZEPINE ANTIPSYCHOTIC AGENT, SCH-39166, AND ITS ACTIVE METABOLITE, SCH-40853, IN HUMAN PLASMA AND ITS CROSS-VALIDATION WITH A GAS-CHROMATOGRAPHIC METHOD

      Journal of chromatography B. Biomedical applications
    28. LEVER JR; SCHEFFEL U; STATHIS M; SELTZMAN HH; WYRICK CD; ABRAHAM P; PARHAM K; THOMAS BF; BOJA JW; KUHAR MJ; CARROLL FI
      SYNTHESIS AND IN-VIVO STUDIES OF A SELECTIVE LIGAND FOR THE DOPAMINE TRANSPORTER - BETA-(4-[I-125]IODOPHENYL)TROPAN-2-BETA-CARBOXYLIC ACID ISOPROPYL ESTER ([I-125]RTI-121)

      Nuclear medicine and biology
    29. MADAR I; LEVER JR; KINTER CM; SCHEFFEL U; RAVERT HT; MUSACHIO JL; MATHEWS WB; DANNALS RF; FROST JJ
      IMAGING OF DELTA-OPIOID RECEPTORS IN HUMAN BRAIN BY N1'-([C-11]METHYL)NALTRINDOLE AND PET

      Synapse
    30. GIFFORD AN; GATLEY SJ; ASHBY CR
      ENDOGENOUSLY RELEASED DOPAMINE INHIBITS THE BINDING OF DOPAMINERGIC PET AND SPECT LIGANDS IN SUPERFUSED RAT STRIATAL SLICES

      Synapse
    31. OSUGA H; HAKIM AM
      RELATIONSHIP BETWEEN EXTRACELLULAR GLUTAMATE CONCENTRATION AND VOLTAGE-SENSITIVE CALCIUM-CHANNEL FUNCTION IN FOCAL CEREBRAL-ISCHEMIA IN THERAT

      Journal of cerebral blood flow and metabolism
    32. TSUKADA H; KREUTER J; MAGGOS CE; UNTERWALD EM; KAKIUCHI T; NISHIYAMA S; FUTATSUBASHI M; KREEK MJ
      EFFECTS OF BINGE PATTERN COCAINE ADMINISTRATION ON DOPAMINE D-1 AND D-2 RECEPTORS IN THE RAT-BRAIN - AN IN-VIVO STUDY USING POSITRON EMISSION TOMOGRAPHY

      The Journal of neuroscience
    33. MURATA T; MATSUMURA K; ONOE H; BERGSTROM M; TAKECHI H; SIHVER S; SIHVER W; NEU H; ANDERSSON Y; OGREN M; FASTH KJ; LANGSTROM B; WATANABE Y
      RECEPTOR IMAGING TECHNIQUE WITH C-11 LABELED RECEPTOR LIGANDS IN LIVING BRAIN-SLICES - ITS APPLICATION TO TIME-RESOLVED IMAGING AND SATURATION ANALYSIS OF BENZODIAZEPINE RECEPTOR USING [C-11] RO15-1788

      Neuroscience research
    34. HUME SP; LAMMERTSMA AA; MYERS R; RAJESWARAN S; BLOOMFIELD PM; ASHWORTH S; FRICKER RA; TORRES EM; WATSON I; JONES T
      THE POTENTIAL OF HIGH-RESOLUTION POSITRON EMISSION TOMOGRAPHY TO MONITOR STRIATAL DOPAMINERGIC FUNCTION IN RAT MODELS OF DISEASE

      Journal of neuroscience methods
    35. GUERRE P; GALTIER P; BURGAT V
      METABOLISM AND SUSCEPTIBILITY TO AFLATOXI NS TOXICITY

      Revue de Medecine Veterinaire
    36. THIBAUT F; VAUGEOIS JM; BONNET JJ; COSTENTIN J
      IN-VIVO STRIATAL BINDING OF THE D-1 ANTAGONIST SCH-23390 IS NOT MODIFIED BY CHANGES IN DOPAMINERGIC TRANSMISSION

      Neuropharmacology
    37. LEVER JR; STATHIS M; KINTER CM; SCHEFFEL U
      IN-VIVO LABELING OF DELTA-OPIOID RECEPTORS IN MOUSE-BRAIN BY [3H]BENZYLIDENENALTREXONE, A LIGAND SELECTIVE FOR THE DELTA(1) SUBTYPE

      Life sciences
    38. KINTER CM; LEVER JR
      SYNTHESIS OF RADIOIODINATED NALTRINDOLE ANALOGS - LIGANDS FOR STUDIESOF DELTA-OPIOID RECEPTORS

      Nuclear medicine and biology
    39. HALL H; HALLDIN C; NYBERG S; FARDE L; SEDVALL G
      EFFECT OF CLOZAPINE AND RISPERIDONE ON 5-HT2 AND D-2-DOPAMINE RECEPTOR-BINDING IN THE POSTMORTEM HUMAN BRAIN - AN AUTORADIOGRAPHIC STUDY

      European neuropsychopharmacology
    40. BREINHOLT V; SCHIMERLIK M; DASHWOOD R; BAILEY G
      MECHANISMS OF CHLOROPHYLLIN ANTICARCINOGENESIS AGAINST AFLATOXIN B-1 - COMPLEX-FORMATION WITH THE CARCINOGEN

      Chemical research in toxicology
    41. DELFORGE J; PAPPATA S; MILLET P; SAMSON Y; BENDRIEM B; JOBERT A; CROUZEL C; SYROTA A
      QUANTIFICATION OF BENZODIAZEPINE RECEPTORS IN HUMAN BRAIN USING PET, [C-11] FLUMAZENIL, AND A SINGLE-EXPERIMENT PROTOCOL

      Journal of cerebral blood flow and metabolism
    42. VESSOTSKIE JM; KUNG MP; CHUMPRADIT S; ROMANIELLO G; MCELGIN W; FREDERICK D; MALISON RT; KUNG HF
      IN-VITRO AND IN-VIVO CHARACTERIZATION OF R(-FIDA2 - A DOPAMINE D2-LIKE IMAGING AGENT())

      The Journal of nuclear medicine
    43. COPPENS HJ; SEBENS JB; KORF J
      CATALEPSY, FOS PROTEIN, AND DOPAMINE-RECEPTOR OCCUPANCY AFTER LONG-TERM HALOPERIDOL TREATMENT

      Pharmacology, biochemistry and behavior
    44. MATSUSHIMA K; HAKIM AM
      TRANSIENT FOREBRAIN ISCHEMIA PROTECTS AGAINST SUBSEQUENT FOCAL CEREBRAL-ISCHEMIA WITHOUT CHANGING CEREBRAL PERFUSION

      Stroke
    45. HOGAN MJ; TAKIZAWA S; HAKIM AM
      IN-VITRO BINDING OF[H-3]NIMODIPINE AND [H-3] CGS-19755 TO RAT-BRAIN IN FOCAL CEREBRAL-ISCHEMIA

      Experimental neurology
    46. PANOCKA I; CICCOCIOPPO R; MOSCA M; POLIDORI C; MASSI M
      EFFECTS OF THE DOPAMINE D-1 RECEPTOR ANTAGONIST SCH-39166 ON THE INGESTIVE BEHAVIOR OF ALCOHOL-PREFERRING RATS

      Psychopharmacology
    47. TAFANI JAM; FRANCES B; COULAIS Y; MEJEANGALZI A; GOELDNER M; HIRTH C; GUIRAUD R; ZAJAC JM
      IN-VIVO BINDING OF [I-125] NH2-CARFENTANIL TO MU-OPIOID RECEPTORS IN MOUSE-BRAIN

      Nuclear medicine and biology
    48. OGREN SO; GOLDSTEIN M
      PHENCYCLIDINE-INDUCED AND DIZOCILPINE-INDUCED HYPERLOCOMOTION ARE DIFFERENTIALLY MEDIATED

      Neuropsychopharmacology
    49. FARDE L; HALLDIN C; MULLER L; SUHARA T; KARLSSON P; HALL H
      PET STUDY OF [C-11] BETA-CIT BINDING TO MONOAMINE TRANSPORTERS IN THEMONKEY AND HUMAN BRAIN

      Synapse
    50. TAKIZAWA S; HOGAN MJ; BUCHAN AM; HAKIM AM
      IN-VIVO BINDING OF [H-3] NIMODIPINE IN RAT-BRAIN AFTER TRANSIENT FOREBRAIN ISCHEMIA

      Journal of cerebral blood flow and metabolism
    51. TICE MAB; HASHEMI T; TAYLOR LA; DUFFY RA; MCQUADE RD
      CHARACTERIZATION OF THE BINDING OF SCH-39166 TO THE 5 CLONED DOPAMINE-RECEPTOR SUBTYPES

      Pharmacology, biochemistry and behavior
    52. SUMIYOSHI T; KIDO H; SAKAMOTO H; URASAKI K; SUZUKI K; YAMAGUCHI N; MORI H; SHIBA K; YOKOGAWA K
      IN-VIVO DOPAMINE-D-2 AND SEROTONIN-5-HT2 RECEPTOR-BINDING STUDY OF RISPERIDONE AND HALOPERIDOL

      Pharmacology, biochemistry and behavior
    53. RINALDICARMONA M; CONGY C; POINTEAU P; VIDAL H; BRELIERE JC; LEFUR G
      IDENTIFICATION OF BINDING-SITES FOR SR-46349B, A 5-HYDROXYTRYPTAMINE(2) RECEPTOR ANTAGONIST, IN RODENT BRAIN

      Life sciences
    54. NOBLE F; SMADJA C; ROQUES BP
      ROLE OF ENDOGENOUS CHOLECYSTOKININ IN THE FACILITATION OF MU-MEDIATEDANTINOCICEPTION BY DELTA-OPIOID AGONISTS

      The Journal of pharmacology and experimental therapeutics
    55. LAPORTE AM; LIMA L; GOZLAN H; HAMON M
      SELECTIVE IN-VIVO LABELING OF BRAIN 5-HT1A-RECEPTORS BY [H-3] WAY-100635 IN THE MOUSE

      European journal of pharmacology
    56. TERRY P; KATZ JL
      A COMPARISON OF THE EFFECTS OF THE D-1 RECEPTOR ANTAGONISTS SCH-23390AND SCH-39166 ON SUPPRESSION OF FEEDING-BEHAVIOR BY THE D-1 AGONIST SKF38393

      Psychopharmacology
    57. SUMIYOSHI T; KIDO H; SAKAMOTO H; URASAKI K; SUZUKI K; YAMAGUCHI N; MORI H; SHIBA K; YOKOGAWA K; ICHIMURA F
      TIME-COURSE OF DOPAMINE-D(2) AND SEROTONIN-5-HT(2) RECEPTOR OCCUPANCYRATES BY HALOPERIDOL AND CLOZAPINE INVIVO

      Japanese journal of psychiatry and neurology
    58. HALL H; HALLDIN C; SEDVALL G
      BINDING OF [H-3] SCH-39166 TO HUMAN POSTMORTEM BRAIN-TISSUE

      Pharmacology & toxicology
    59. BILLINGS JJ; GUO YZ; KUNG MP; KUNG HF
      LOCALIZATION OF IBF AS A D-2 DOPAMINE-RECEPTOR IMAGING AGENT IN NONHUMAN-PRIMATES

      European journal of nuclear medicine
    60. DELFORGE J; SYROTA A; BOTTLAENDER M; VARASTET M; LOCH C; BENDRIEM B; CROUZEL C; BROUILLET E; MAZIERE M
      MODELING ANALYSIS OF [C-11] FLUMAZENIL KINETICS STUDIED BY PET - APPLICATION TO A CRITICAL-STUDY OF THE EQUILIBRIUM APPROACHES

      Journal of cerebral blood flow and metabolism
    61. DOBLE A; CANTON T; DREISLER S; PIOT O; BOIREAU A; STUTZMANN JM; BARDONE MC; RATAUD J; ROUX M; ROUSSEL G; BOURZAT JD; COTREL C; PAUCHET C; ZUNDEL JL; BLANCHARD JC
      RP-59037 AND RP-60503 - ANXIOLYTIC CYCLOPYRROLONE DERIVATIVES WITH LOW SEDATIVE POTENTIAL - INTERACTION WITH THE GAMMA-AMINOBUTYRIC-ACID (A) BENZODIAZEPINE RECEPTOR COMPLEX AND BEHAVIORAL-EFFECTS IN THE RODENT

      The Journal of pharmacology and experimental therapeutics
    62. ONGINI E; BONIZZONI E; FERRI N; MILANI S; TRAMPUS M
      DIFFERENTIAL-EFFECTS OF DOPAMINE D-1 AND D-2 RECEPTOR ANTAGONIST ANTIPSYCHOTICS ON SLEEP-WAKE PATTERNS IN THE RAT

      The Journal of pharmacology and experimental therapeutics
    63. MATSUBARA S; MATSUBARA R; KUSUMI I; KOYAMA T; YAMASHITA I
      DOPAMINE-D(1), DOPAMINE-D(2) AND SEROTONIN(2) RECEPTOR OCCUPATION BY TYPICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS INVIVO

      The Journal of pharmacology and experimental therapeutics
    64. ANTONINI A; LEENDERS KL; REIST H; THOMANN R; BEER HF; LOCHER J
      EFFECT OF AGE ON D(2)-DOPAMINE RECEPTORS IN NORMAL HUMAN BRAIN MEASURED BY POSITRON EMISSION TOMOGRAPHY AND C-11 RACLOPRIDE

      Archives of neurology
    65. TEDFORD CE; COFFIN VL; RUPERTO V; COHEN M; MCQUADE RD; JOHNSON R; KIM HK; LIN CC
      DETERMINATION OF PLASMA AND BRAIN CONCENTRATIONS OF SCH-39166 AND THEIR CORRELATION TO CONDITIONED AVOIDANCE-BEHAVIOR IN RATS

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 01:21:53